2024
Multiply robust estimation of principal causal effects with noncompliance and survival outcomes
Cheng C, Guo Y, Liu B, Wruck L, Li F, Li F. Multiply robust estimation of principal causal effects with noncompliance and survival outcomes. Clinical Trials 2024, 21: 553-561. PMID: 38813813, DOI: 10.1177/17407745241251773.Peer-Reviewed Original ResearchMeSH KeywordsAspirinCardiovascular DiseasesCausalityHospitalizationHumansModels, StatisticalPragmatic Clinical Trials as TopicResearch DesignSurvival AnalysisConceptsPrincipal strataRight-censored survival outcomesPrincipal causal effectsCausal effectsSensitivity analysis strategyPrincipal ignorabilityRobust estimationIdentification assumptionsCensoringPragmatic clinical trialsTreatment assignmentTreatment noncomplianceMonotonicityEstimationAssess treatment effectsCardiovascular diseaseClinical trialsMultipliersTreatment effectsAssumptionsNoncompliance
2022
Pragmatic clinical trial design in emergency medicine: Study considerations and design types
Gettel CJ, Yiadom MYAB, Bernstein SL, Grudzen CR, Nath B, Li F, Hwang U, Hess EP, Melnick ER. Pragmatic clinical trial design in emergency medicine: Study considerations and design types. Academic Emergency Medicine 2022, 29: 1247-1257. PMID: 35475533, PMCID: PMC9790188, DOI: 10.1111/acem.14513.Peer-Reviewed Original ResearchConceptsPragmatic clinical trialsClinical trial designTrial designReal-world clinical practicePragmatic clinical trial designElectronic health recordsEmergency departmentClinical trialsStudy design typeClinical practiceStudy typeTrial componentsHealth recordsEmergency medicineEmergency medicine investigatorsHuman subjects concernsInvestigatorsStudy findingsStudy considerationsTrialistsTrials
2021
Methodological challenges in pragmatic trials in Alzheimer’s disease and related dementias: Opportunities for improvement
Taljaard M, Li F, Qin B, Cui C, Zhang L, Nicholls SG, Carroll K, Mitchell SL. Methodological challenges in pragmatic trials in Alzheimer’s disease and related dementias: Opportunities for improvement. Clinical Trials 2021, 19: 86-96. PMID: 34841910, PMCID: PMC8847324, DOI: 10.1177/17407745211046672.Peer-Reviewed Original ResearchMeSH KeywordsAlzheimer DiseaseCaregiversCluster AnalysisHumansPragmatic Clinical Trials as TopicRandomized Controlled Trials as TopicResearch DesignResearch ReportConceptsPragmatic trialAlzheimer's diseasePrimary outcomeSample size calculationGroup treatment trialsPairs of reviewersDementia researchSize calculationCluster Randomized TrialGroup treatment designRandomized trialsTreatment trialsIntracluster correlationMethodological qualityTrial reportsBaseline assessmentDiseaseTrialsDementiaKey methodological characteristicsOutcomesType IMethodological quality indicatorsUnique methodological challengesSame individual
2020
Statistical Considerations for Embedded Pragmatic Clinical Trials in People Living with Dementia
Allore HG, Goldfeld KS, Gutman R, Li F, Monin JK, Taljaard M, Travison TG. Statistical Considerations for Embedded Pragmatic Clinical Trials in People Living with Dementia. Journal Of The American Geriatrics Society 2020, 68: s68-s73. PMID: 32589276, PMCID: PMC7396162, DOI: 10.1111/jgs.16616.Peer-Reviewed Original ResearchMeSH KeywordsCaregiversDelivery of Health CareDementiaHumansModels, StatisticalPragmatic Clinical Trials as TopicReproducibility of ResultsResearch DesignConceptsEmbedded Pragmatic Clinical TrialsPragmatic clinical trialsClinical trialsAlzheimer's diseaseImbedded Pragmatic Alzheimer's DiseaseIMPACT CollaboratoryOutcome ascertainmentPoint of careNonpharmacological interventionsReal-world settingComplex interventionsTrialsIntervention effectivenessVulnerable populationsPragmatic designHealthcare systemNational InstituteClinical scientistsSuch interventionsInterventionDementiaPLWDDiseaseCaregiversResearch priorities
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply